Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Vision Medicals, a China-based gene-sequencing technology developer backed by Chinese Academy of Sciences, has raised RMB300m ($47m) in a series D round featuring internet and gaming group Tencent, DealStreetAsia reported today, citing a company statement. Boyu Capital, CDH Venture and Growth Capital, a vehicle for alternative asset management firm CDH, also took part in the round. Cash Capital, an investment vehicle for Chinese Academy of Sciences, was among the investors in a $30.9m series C round in February 2021.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).